Literature DB >> 12833522

Proteomic analysis of human vessels: application to atherosclerotic plaques.

Mari Carmen Duran1, Sebastian Mas, Jose Luis Martin-Ventura, Olivier Meilhac, Jean Baptiste Michel, Julio Gallego-Delgado, Alberto Lázaro, José Tuñon, Jesus Egido, Fernando Vivanco.   

Abstract

Atherosclerosis is a chronic disease that affects medium and large arteries. This process originates from the interaction between cells of the arterial wall, lipoproteins and inflammatory cells, leading to the development of complex lesions or plaques that protrude into the arterial lumen. Plaque rupture and thrombosis result in acute clinical complications such as myocardial infarction and stroke. Owing to the heterogeneous cellular composition of the plaques, a proteomic analysis of the whole lesion is not appropriate. Therefore, we have studied the proteins secreted by human carotid atherosclerotic plaques, obtained by endarterectomy. Normal artery segments and different regions of the surgical pieces (noncomplicated plaque, complicated plaque with thrombus) were cultured in protein-free medium and the secreted proteins (supernatants) analyzed by two-dimensional gel electrophoresis. Normal artery segments secreted a moderate number of proteins (42 spots). However in the two-dimensional (2-D) gels (pH 3-10) of segments bearing a plaque, the number of spots increased markedly (154). The number of spots also increased (202) in the 2-D gels of artery segments with a ruptured plaque and thrombus. Thus, the more complicated the lesion, the higher the number of secreted proteins, suggesting the production of specific proteins relating to the complexity of the atherosclerotic lesion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12833522     DOI: 10.1002/pmic.200300389

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  19 in total

1.  Transcriptional regulation of beta2-microglobulin demonstrated via a novel genomic and proteomic analysis of percutaneously collected peripheral atheroma.

Authors:  Brian L Stauffer; Erich J Kushner; Ted Wulfman; Thomas Zeller; Rebecca Sobus; Christian M Westby
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  Preoteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

3.  An optimal protocol to analyze the rat spinal cord proteome.

Authors:  F Gil-Dones; S Alonso-Orgaz; G Avila; T Martin-Rojas; V Moral-Darde; G Barroso; F Vivanco; J Scott-Taylor; M G Barderas
Journal:  Biomark Insights       Date:  2009-10-28

4.  Valvular aortic stenosis: a proteomic insight.

Authors:  Felix Gil-Dones; Tatiana Martin-Rojas; Luis F Lopez-Almodovar; Fernando de la Cuesta; Veronica M Darde; Gloria Alvarez-Llamas; Rocio Juarez-Tosina; Gemma Barroso; Fernando Vivanco; Luis R Padial; Maria G Barderas
Journal:  Clin Med Insights Cardiol       Date:  2010-02-04

Review 5.  Cardiovascular proteomics: past, present, and future.

Authors:  Melanie Y White; Jennifer E Van Eyk
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

6.  Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension.

Authors:  Sandrine Delbosc; Mounsif Haloui; Liliane Louedec; Morgan Dupuis; Myriam Cubizolles; Vladimir N Podust; Eric T Fung; Jean-Baptiste Michel; Olivier Meilhac
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

7.  Investigating the secretome: lessons about the cells that comprise the heart.

Authors:  Miroslava Stastna; Jennifer E Van Eyk
Journal:  Circ Cardiovasc Genet       Date:  2012-02-01

8.  A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries.

Authors:  Antonio J Lepedda; Antonio Cigliano; Gian Mario Cherchi; Rita Spirito; Marco Maggioni; Franco Carta; Franco Turrini; Celina Edelstein; Angelo M Scanu; Marilena Formato
Journal:  Atherosclerosis       Date:  2008-07-12       Impact factor: 5.162

Review 9.  Challenges, current status and future perspectives of proteomics in improving understanding, diagnosis and treatment of vascular disease.

Authors:  J V Moxon; M P Padula; B R Herbert; J Golledge
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-07-09       Impact factor: 7.069

10.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.